Exor Capital LLP Insulet Corp Transaction History
Exor Capital LLP
- $3.23 Billion
- Q3 2024
A detailed history of Exor Capital LLP transactions in Insulet Corp stock. As of the latest transaction made, Exor Capital LLP holds 15,937 shares of PODD stock, worth $4.19 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
15,937
Previous 16,069
0.82%
Holding current value
$4.19 Million
Previous $3.24 Million
14.4%
% of portfolio
0.11%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding PODD
# of Institutions
685Shares Held
62.7MCall Options Held
640KPut Options Held
881K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.23 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.04 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.59 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$766 Million0.03% of portfolio
-
Baillie Gifford & CO2.28MShares$598 Million0.4% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.2B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...